123 / 156
539
103. Borghesi A, Cova C, Gazzolo D, Stronati M. Stem cell therapy
for neonatal diseases associated with preterm birth. J Clin
Neonatol 2013;2(1):1-7.
104. Lee JW, Fang X, Krasnodembskaya A, Howard JP, Matthay
MA Concise review: mesenchymal stem cells for acute lung
injury: role of paracrine soluble factors. Stem Cells (2011)
29(6):913–919.
105. Phillips AW, Johnston MV, Fatemi A The potential for cell-
based therapy in perinatal brain injuries. Transl Stroke Res
(2013) 4(2):137–148.
106. Fung ME, Thebaud B. Stem cell-based therapy for neonatal
lung disease: it is in the juice. Pediatr Res 2014;75:2-7.
107. Kotton DN, Morrisey EE Lung regeneration: mechanisms,
applications and emerging stem cell populations. Nat Med
(2014) 20(8):822–832.
108. Stabler CT, Lecht S, Lazarovici P, Lelkes PI Mesenchymal stem
cells for therapeutic applications in pulmonary medicine. Br
Med Bull. doi: (2015) 10.1093/ bmb/ldv026
109. Aslam M, Baveja R, Liang OD, et al. Bone marrow stromal
cells attenuate lung injury in a murine model of neonatal
chronic lung disease. Am J Respir Crit Care Med 2009;
180(11):1122-30.
110. Tropea KA, Leder E, Aslam M, et al. Bronchioalveolar stem
cells increase after mesenchymal stromal cell treatment in
a mouse model of bronchopulmonary dysplasia. Am J Physiol
Lung Cell Mol Physiol 2012;302(9):829-37.
111. Zhang H, Fang J, Su H, et al. Bone marrow mesenchymal stem
cells attenuate lung inflammation of hyperoxic newborn
rats. Pediatr Transplant 2012;16(6):589-98.
112. Chang YS, Choi SJ, SungDK, et al. Intratracheal transplantation
of human umbilical cord blood-derived mesenchymal stem
cells dose-dependently attenuates hyperoxia-induced lung
injury in neonatal rats. Cell Transplant 2011;20(11-12):
1843-54.
113. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et
al Intravenous hMSCs improve myocardial infarction in mice
because cells embolized in lung are activated to secrete the
anti-inflammatory protein TSG-6. Cell Stem Cell (2009)
5(1):54–63.
114. Pluchino S, Cossetti C How stem cells speak with host
immune cells in inflammatory brain diseases. Glia (2013)
61(9):1379–1401.
115. Ribeiro CA, Salgado AJ, Fraga JS, Silva NA, Reis RL, et al
The secretome of bone marrow mesenchymal stem cells-
conditioned media varies with time and drives a distinct
effect on mature neurons and glial cells (primary cultures). J
Tissue Eng Regen Med (2011) 5(8):668–672.
116. Glenn JD, Whartenby KA Mesenchymal stem cells: emerging
mechanisms of immunomodulation and therapy. World J
Stem Cells (2014) 6(5): 526–539.
117. Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, et al The
meaning, the sense and the significance: translating the
science of mesenchymal stem cells into medicine. Nat Med
(2013) 19(1):35–42
118. Uccelli A, Benvenuto F, Laroni A, Giunti D Neuroprotective
features of mesenchymal stem cells. Best Pract Res Clin
Haematol (2011) 24(1):59–64.
119. Krause B, Castro-Rodríguez J, Uauy R, Casanello P. Conceptos
generales de epigenética: proyecciones en Pediatría. Rev.
Chil.Pediatr. (2016); 87 (1): 4-10.
120. Squillaro T, Peluso G, Galderisi U. Clinical Trials With
Mesenchymal Stem Cells: An Update. Cell Transplantation
(2016); 25: 829-848.
121. Fabián M, Rodríguez B, Álvarez Pérez M. Aislamiento y
caracterización parcial de células madre de pulpa dental.
Revista Odontológica Mexicana (2010); 14 (1): 15-20.
122. O’Reilly M, Thébaud B. Stem Cells for the Prevention of
Neonatal Lung Disease. Neonatology (2015);107:360-364
123. Lanfranchi A, Porta F, Chirico G. Stem cells and the frontiers
of neonatology Early Hum Dev. 2009 Oct (2009);85(10
Suppl):S15-18.
124. Oyarzún E. Células madres: nuevas fronteras para lamedicina.
Rev. Chil. Obstet. Ginecol. (2005) 70( 4 ): 211-212.
125. Salinas H, Adauy A, Ide R.. Reflexiones acerca de células
troncales obtenidas mediante la utilización de embriones
humanos. Rev. Chil. Obstet. Ginecol. (2005) 70(4), 264-271
[TERAPIA REGENERATIVA EN NEONATOLOGÍA - Dr. Hernán Villalón y cols.]